Chintu Patel - Net Worth and Insider Trading

Chintu Patel Net Worth

The estimated net worth of Chintu Patel is at least $4 Million dollars as of 2024-12-11. Chintu Patel is the Co-CEO of Amneal Pharmaceuticals Inc and owns about 512,566 shares of Amneal Pharmaceuticals Inc (AMRX) stock worth over $4 Million. Details can be seen in Chintu Patel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chintu Patel has not made any transactions after 2021-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Chintu Patel

To

Chintu Patel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Chintu Patel owns 1 companies in total, including Amneal Pharmaceuticals Inc (AMRX) .

Click here to see the complete history of Chintu Patel’s form 4 insider trades.

Insider Ownership Summary of Chintu Patel

Ticker Comapny Transaction Date Type of Owner
AMRX Amneal Pharmaceuticals Inc 2021-12-16 director

Chintu Patel Latest Holdings Summary

Chintu Patel currently owns a total of 1 stock. Chintu Patel owns 512,566 shares of Amneal Pharmaceuticals Inc (AMRX) as of December 16, 2021, with a value of $4 Million.

Latest Holdings of Chintu Patel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMRX Amneal Pharmaceuticals Inc 2021-12-16 512,566 8.15 4,177,413

Holding Weightings of Chintu Patel


Chintu Patel Form 4 Trading Tracker

According to the SEC Form 4 filings, Chintu Patel has made a total of 3 transactions in Amneal Pharmaceuticals Inc (AMRX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Amneal Pharmaceuticals Inc is the acquisition of 150,000 shares on December 16, 2021, which cost Chintu Patel around $625,500.

Insider Trading History of Chintu Patel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Chintu Patel Trading Performance

GuruFocus tracks the stock performance after each of Chintu Patel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chintu Patel is 23.95%. GuruFocus also compares Chintu Patel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chintu Patel within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Chintu Patel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Chintu Patel

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.63 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.31 LIMIT LIMIT LIMIT LIMIT LIMIT

Chintu Patel Ownership Network

Ownership Network List of Chintu Patel

No Data

Ownership Network Relation of Chintu Patel

Insider Network Chart

Chintu Patel Owned Company Details

What does Amneal Pharmaceuticals Inc do?

Who are the key executives at Amneal Pharmaceuticals Inc?

Chintu Patel is the director of Amneal Pharmaceuticals Inc. Other key executives at Amneal Pharmaceuticals Inc include SVP & Chief Legal Officer Jason B. Daly , Exec VP & Comm Optns Andrew S Boyer , and SVP & Chief HR Officer Nikita Shah .

Amneal Pharmaceuticals Inc (AMRX) Insider Trades Summary

Over the past 18 months, Chintu Patel made no insider transaction in Amneal Pharmaceuticals Inc (AMRX). Other recent insider transactions involving Amneal Pharmaceuticals Inc (AMRX) include a net sale of 92,013 shares made by Andrew S Boyer , a net sale of 78,000 shares made by Deborah M. Autor , and a net sale of 57,322 shares made by Jason B. Daly .

In summary, during the past 3 months, insiders sold 114,380 shares of Amneal Pharmaceuticals Inc (AMRX) in total and bought 0 shares, with a net sale of 114,380 shares. During the past 18 months, 344,393 shares of Amneal Pharmaceuticals Inc (AMRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 344,393 shares.

Amneal Pharmaceuticals Inc (AMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amneal Pharmaceuticals Inc Insider Transactions

No Available Data

Chintu Patel Mailing Address

Above is the net worth, insider trading, and ownership report for Chintu Patel. You might contact Chintu Patel via mailing address: C/o Amneal Pharmaceuticals Llc, 400 Crossing Boulevard, Bridgewater Ca 08807.